Randomized Trial of Ticagrelor for Severe Community Acquired Pneumonia
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary)
- Indications Community-acquired pneumonia
- Focus Therapeutic Use
- Acronyms TCAP
- 10 Mar 2016 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 05 Aug 2014 Planned End Date changed from 1 Sep 2016 to 1 Nov 2016 as reported by ClinicalTrials.gov.